The Lancet. Haematology

Lancet Haematol · ISSN (e) 2352-3026 · 1 paper in corpus
other 2016
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
doi:10.1016/S2352-3026(15)00251-3 ·PMID:26853646

BACKGROUND: Livedoid vasculopathy is a thrombotic skin disease characterised by recurrent occlusion of the cutaneous microcirculation in lower extremities, which results in skin infarctions with painful ulcerations and irreversible scar for…